Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
1 Dead in Suspected Russia Plague Case as CDC, US Press Moscow
MENAFN
(MENAFN) U.S. health officials are tracking a suspected case of pneumonic plague in Russia's Irkutsk region that has left one person dead, the Centers for Disease Control and Prevention (CDC) said Tuesday, as Washington pressed Moscow for more...
Alvotech to present at upcoming investor conferences in September
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Robert...
Costco Wholesale Corporation Announces Quarterly Cash Dividend
GlobeNewswire, Inc.
ISSAQUAH, Wash., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced that its Board of Directors has declared a quarterly cash dividend on Costco common stock of $1.47 per...
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
Alvotech announces successful closure of FDA inspection of manufacturing facility
GlobeNewswire, Inc.
REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced...
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
GlobeNewswire, Inc.
ZUG, Switzerland, August 24th, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology, today...
Alvotech to Report Financial Results for H1 2026
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced...
High Levels of Trust Elevate the Fortune 100 Best Companies to Work For, Europe in 2026
GlobeNewswire, Inc.
Oakland, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Great Place To Work® and Fortune Europe announce the 2026 Fortune 100 Best Companies to Work For™ Europe, highlighting the best employers, regardless of industry or country of origin.
Costco Wholesale Corporation Reports September Sales Results
GlobeNewswire, Inc.
ISSAQUAH, Wash., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $30.02 billion for the retail month of September, the five weeks ended October 4, 2026, an...
Axelyf and Mote Therapeutics Form Alliance to Provide Off-the-Shelf In Vivo T-Cell Targeted Delivery for Nucleic Acids
EIN Presswire
BOSTON, MA, UNITED STATES, September 9, 2026 /EINPresswire.com/ -- Axelyf, Inc. and Mote Therapeutics today announced a cross-license agreement to provide a complete, targeted T-cell delivery solution combining Axelyf’s lipid nanoparticle (LNP)...
Travel Sterilizing Buckets Market Insights Report Analyzing Demand Trends And Competitive Positioning
EIN Presswire
The Business Research Company's Travel Sterilizing Buckets Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2026 /EINPresswire.com/ -- "The travel sterilizing buckets...
Oculis Reports Q2 2026 Financial Results and Provides Company Update
GlobeNewswire, Inc.
Company pivot to neuro-ophthalmology continues with Privosegtor positioned as lead late-stage asset through the registrational PIONEER program with expansion potential in acute multiple sclerosis (MS) relapses following positive FDA pre-IND...
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
GlobeNewswire, Inc.
The FDA Division of Neurology provided positive feedback supporting a regulatory pathway for Privosegtor in acute multiple sclerosis (MS) relapses, addressing a significant unmet medical need The FDA confirmed that existing Privosegtor data can be...
Rubio Says Russian Lab Incident Requires Monitoring Yet No Alarm
MENAFN
(MENAFN) US Secretary of State Marco Rubio said Monday that an infection incident at a biological research facility in Russia does not currently represent a reason for alarm, while confirming that US authorities are closely following the...
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
GlobeNewswire, Inc.
REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S....
86th MDG stretches aeromedical evacuation capabilities in the High North during Northern Viking 26
DVIDS - Georgia
KEFLAVIK AIR BASE, ICELAND -- U.S. Air Force medical personnel of the 86th Medical Squadron and 86th Aeromedical Evacuation Squadron from Ramstein Air Base\, Germany\, are taking part in exercise Northern Viking 26\, bringing 86th Medical...
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
GlobeNewswire, Inc.
Transaction will enhance Oculis’ strategic flexibility and ownership of Privosegtor while driving long-term value creation Transaction consideration includes $3.8 million up-front cash payment at closing and up to 2,050,000 Oculis ordinary shares...
HSD Employee Spotlight—Michelle Smith
Seattle City - Washington State
October is Domestic Violence Awareness Month.
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
GlobeNewswire, Inc.
REYKJAVIK, Iceland, June 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement
GlobeNewswire, Inc.
REYKJAVIK, Iceland, June 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
Sign up for:
Iceland Health Focus
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.